Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Use of CBD and the FDA — It’s so important to do research, read carefully before assuming and / or jumping into conclusions. This Company is doing its homework, so it’s not going to jeopardize things over being uninformed. They hire key people specifically for research. https://cbdclinicals.com/is-cbd-oil-approved-by-fda/
ACQUISITIONS & MERGERS —This lengthy article should provide some better understanding of acquisitions and mergers within the Biopharma / Pharmaceutical Space, in terms of goals and importance of which. https://www.pharmasalmanac.com/articles/understanding-a-dynamic-industry-through-mergers-and-acquisitions
Definitive Purchase Agreement and Deal Closing / Sealing
Generally, there is a time gap between the signing of the agreement and the closing of the deal, as certain regulatory approval is required. With such a time gap, there are certain conditions from both parties that must be met for a successful closing of the deal. If certain conditions are not met, then the other party is not required to close the transaction.
Some of the popular closing conditions in a Definitive Purchase Agreement are:
Buyer should ask for reps and warranties to be accurate as of the signing, as well as of the closing date.
Buyer and seller can also negotiate how accurate the reps and warranties need to be, as all reps can’t be standardized.
Material Adverse Effect is something that is significant for determining whether the conditions to closing are satisfied or not.
Hardlesson, you’re making a lot of sense with your analogy.
Indeed, not sealed yet... SLC-JD, thanks for being on the same page — in making sense.
Things are unfolding behind closed doors. It’s now a matter of time before more filings are dropped. With the 2 billion OS, this one is bound to run hard once (buying) trading restrictions are lifted throughout the U.S, by means of Limited or full-blown Pink Current — to the point of going parabolic.
For crying out loud, I understand what acquired means. I’m referring to the whole deal, as a package, which can potentially be derailed until it’s sealed.
*The deal “isn’t “ sealed yet. (correction)
If a deal is being finalized in private, why should he come out now, mention which Company? It can potentially jeopardize the deal. The deal is sealed yet. It’s preferable that he keeps quiet about it for now. People basically need to be patient, wait.
The CEO has already mentioned that details of the acquisition [including which Company] will be provided. Why / how come some people are acting as though they didn’t understand? Why so impatient?
Agreements have been set forth for RCHA to proceed with filings, and all will move forward, as long as there are no objections between any parties by the 18th of this month.
No, you can’t buy it through Schwab for now. Go to TD Ameritrade or E-Trade.
After their 8-K filing, they’re now filing the S-1 form, seeking to go public. I’m guessing they’re also up for a potential buyout, by a Company that’s Pink Current. Indeed, September’s imposed rules will destroy them if no meaningful move is made beforehand.
Back from the dead?
Why is it currently not trading, with filings?
King RGBP / Regen Biopharma Inc.
New Article insert-text-here
Some people don’t seem to get it, which is sad. Better days are ahead for this Company. There are so many catalysts to bring optimism way up.
Patents assigned to Regen Biopharma, and many more are about to be revived. https://patents.justia.com/assignee/regen-biopharma-inc
Regen Biopharma — Short Article https://flipfigures.com/regen-biopharma-rgbp-stock-attempts-to-recover-whats-the-buzz/
Let’s hope President Biden’s speech will give RGBP a much-needed boost today. https://www.cbsnews.com/news/biden-speech-congress-joint-session-cancer-health-proposal/
If you are a shareholder in RGBP, you need to read this interesting article. https://investingbulletin.com/2021/04/regen-biopharma-inc-rgbp-signals-its-ambition-to-go-otc-pink-current-with-recent-8k-filing/
Here’s a great article that you certainly need to read and share. https://www.hvst.com/posts/one-day-it-will-be-too-late-wZrTgOMG
Let’s all agree that the next run will be UNSTOPPABLE. No one can accurately tell / predict when, but when it does... It’s currently in teasing mode, comfortably resting before it does its thing.
No one would (invest) spend money to renew patent(s) just for fun, or just for the heck of it. It tells you that something is being worked on. The Company might not be active for the time being, but don’t be fooled. Focus on the word, PATENT, to better understand things. I’m sensing it’s a matter of time before some fresh news develop. News might be coming from a new CEO who’s taking over. Their patent techniques are top notch, similar to the ones of RGBP. Anyway, these are just my own opinions. I’m not a Financial Advisor, so this is not advice to purchase shares. You do your own due diligence.
No one would (invest) spend money to renew patent(s) just for fun, or just for the heck of it. It tells you that something is being worked on. The Company might not be active for the time being, but don’t be fooled. Focus on the word, PATENT, to better understand things. I’m sensing it’s a matter of time before some fresh news develop. News might be coming from a new CEO who’s taking over. Their patent techniques are top notch, similar to the ones of RGBP. Anyway, these are just my own opinions. I’m not a Financial Advisor, so this is not advice to purchase shares. You do your own due diligence.
Tomorrow, Monday, April 19, will get quite interesting for this stock. It’s being saved from bankruptcy by two major Corporations. Also, the transportation (fleet) sector is picking up. It’s now at $1.70 and I won’t be surprised if it hits $3.00 by Friday. Let’s see what happens...
If this piece of updated news doesn’t get you excited about RGBP, you just don’t understand the vast potentials. https://marketwirenews.com/news-releases/oncology-pharma-inc-addresses-pancreatic-cancer-the--6461887194953135.html.
Now that MCET is being widely exposed and known to many Folks and Institutional Investors, it’s now a matter of time before some major Corporation offers an [a buy-out] acquisition or merger. They seem to possess exceptional patents, and pending patents. I’m sensing that too many people are missing out on RGBP, and they’re fiercely trying to catch up with the next sub penny Biotech [stock] run. I suspect it will take off like a rock just like RGBP. The take-off might be happening now, or certainly in the very near future. Once they update on necessary (paperwork) fillings with the SEC, the rest is history. These are just my own opinions, as I’m not a Financial Advisor or any sort of Financial Expert. I’m just going by common sense and intuition.
The conversion will automatically happen, from one name to another, without any disturbance in your shares. That’s how it’s usually done. I’m also interested to buy shares. They seem to have a unique business model. This stock is very much under the radar. It appears that bids aren’t being accepted for the time being. It might be a matter of time being it comes back to life. I’m watching it.
I suspect they’re doing things behind the scene, on the verge of updating shareholders. https://www.zacks.com/stock/research/PHRX/company-reports
Pump & Dump Stock